Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion (068270 KP)
Watchlist
22
Analysis
Health Care
•
South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Samsung Biologics
•
05 Feb 2017 16:08
Revisiting Samsung BioLogics at This Interesting Time
I don't really intend to make any investment recommendation on BioLogics at this point. I have to admit that I'm still feeling the current price is...
Sanghyun Park
Follow
248 Views
Share
bullish
•
Thematic (Sector/Industry)
•
31 Jan 2017 22:29
Korea Stock Market Monthly Recap #10 - (January 2017)
The Trump economic hope continued to positively impact emerging markets, including Korea. KOSPI was up 2% in January 2017, versus our model...
Douglas Kim
Follow
323 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Jan 2017 09:45
Whale Watching in the Korea Stock Market
There is an adage in the financial market that says, "Don't fight the FED." In the Korea Stock Market, there is an adage that says, "Don't fight...
Douglas Kim
Follow
247 Views
Share
bearish
•
Celltrion Inc
•
20 Jan 2017 20:59
Recent Developments Not Encouraging
This Insight provides an update on developments in the US market related to biosimilars, and are of great significance to Celltrion Inc (068270...
Kemp Dolliver, CFA
159 Views
Share
bullish
•
Eubiologics
•
13 Jan 2017 00:29
Eubiologics IPO Part 3 - IPO Bookbuilding Results & Personal View
Eubiologics IPO price was set at ₩6,000, the lowest end of the indicative price band, after conducting the demand survey (bookbuilding) (Jan 9-10)...
Sanghyun Park
Follow
471 Views
Share
First
Previous
88
89
90
91
92
93
94
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x